Polar Capital Holdings PLC Eli Lilly & CO Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Polar Capital Holdings PLC holds 97,935 shares of LLY stock, worth $73.3 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

97,935

Previous 99,212 1.29%

Holding current value

$73.3 Million

Previous $89.8 Million 3.41%

% of portfolio

0.53%

Previous 0.55%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $986,022 - $1.23 Million	-1,277 Reduced 1.29%	97,935 $86.8 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $13.9 Million - $17.5 Million	-19,231 Reduced 16.24%	99,212 $89.8 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $4.68 Million - $6.26 Million	7,902 Added 7.15%	118,443 $92.1 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $4.99 Million - $5.89 Million	-9,509 Reduced 7.92%	110,541 $64.4 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $7.32 Million - $10.1 Million	-16,841 Reduced 12.3%	120,050 $64.5 Million
Q2 2023 Dec 13, 2023	SELL	$350.74 - $468.98 $646,063 - $863,861	-1,842 Reduced 1.33%	136,891 $64.2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $646,063 - $863,861	-1,842 Reduced 1.33%	136,891 $64.2 Million
Q1 2023 Dec 13, 2023	BUY	$310.63 - $364.82 $5.8 Million - $6.82 Million	18,683 Added 15.56%	138,733 $47.6 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4.14 Million - $4.86 Million	-13,320 Reduced 8.76%	138,733 $47.6 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $12.5 Million - $14.6 Million	38,915 Added 34.4%	152,053 $55.6 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $22 Million - $25.1 Million	74,144 Added 190.14%	113,138 $36.6 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.74 Million - $2.05 Million	-6,254 Reduced 13.82%	38,994 $12.6 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $420,564 - $522,654	-1,792 Reduced 3.81%	45,248 $13 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.9 Million - $2.34 Million	8,588 Added 22.33%	47,040 $10.9 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6.94 Million - $8.98 Million	38,452 New	38,452 $8.83 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $10.7 Million - $13.8 Million	-64,908 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $8.47 Million - $11.2 Million	64,908 New	64,908 $11 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Eli Lilly & CO Transaction History